Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 271

1.

Risks of Herpes Zoster in Patients with Rheumatoid Arthritis According to Biologic Disease Modifying Therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Arthritis Care Res (Hoboken). 2014 Sep 8. doi: 10.1002/acr.22470. [Epub ahead of print]

PMID:
25201241
[PubMed - as supplied by publisher]
2.

Fracture mortality: associations with epidemiology and osteoporosis treatment.

Sattui SE, Saag KG.

Nat Rev Endocrinol. 2014 Oct;10(10):592-602. doi: 10.1038/nrendo.2014.125. Epub 2014 Aug 5. Review.

PMID:
25091729
[PubMed - as supplied by publisher]
3.

Fractures and mortality in relation to different osteoporosis treatments.

Yun H, Delzell E, Saag KG, Kilgore ML, Morrisey MA, Muntner P, Matthews R, Guo L, Wright N, Smith W, Colón-Emeric C, O'Connor CM, Lyles KW, Curtis JR.

Clin Exp Rheumatol. 2014 Jul 28. [Epub ahead of print]

PMID:
25068266
[PubMed - as supplied by publisher]
4.

Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG.

Med Care. 2014 Aug;52(8):743-50. doi: 10.1097/MLR.0000000000000170.

PMID:
24984211
[PubMed - indexed for MEDLINE]
5.

Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.

Curtis JR, Zhang J, Xie F, Beukelman T, Chen L, Fernandes J, Ginsberg S, Spettell C, Yun H, Saag KG, Schiff M.

Arthritis Care Res (Hoboken). 2014 Jun 18. doi: 10.1002/acr.22383. [Epub ahead of print]

PMID:
24942466
[PubMed - as supplied by publisher]
6.

Developing a bone mineral density test result letter to send to patients: a mixed-methods study.

Edmonds SW, Solimeo SL, Lu X, Roblin DW, Saag KG, Cram P.

Patient Prefer Adherence. 2014 Jun 5;8:827-41. doi: 10.2147/PPA.S60106. eCollection 2014.

PMID:
24940049
[PubMed]
Free PMC Article
7.

A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned.

Miller MJ, Allison JJ, Cobaugh DJ, Ray MN, Saag KG.

J Eval Clin Pract. 2014 Oct;20(5):638-48. doi: 10.1111/jep.12193. Epub 2014 Jun 11.

PMID:
24916786
[PubMed - in process]
8.

Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.

Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J.

Clin Ther. 2014 Jun 1;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012. Epub 2014 May 23.

PMID:
24863260
[PubMed - in process]
Free Article
9.

Bone safety of low-dose glucocorticoids in rheumatic diseases.

Saag KG.

Ann N Y Acad Sci. 2014 May;1318:55-64. doi: 10.1111/nyas.12446. Epub 2014 May 9.

PMID:
24815076
[PubMed - indexed for MEDLINE]
10.

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine.

Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B.

J Bone Miner Res. 2014 Apr 26. doi: 10.1002/jbmr.2269. [Epub ahead of print]

PMID:
24771492
[PubMed - as supplied by publisher]
11.

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Ann Rheum Dis. 2014 Mar 7. doi: 10.1136/annrheumdis-2013-204011. [Epub ahead of print]

PMID:
24608404
[PubMed - as supplied by publisher]
12.

Tumor necrosis factor, tuberculosis, testing, and treatment: teeing up the questions.

Saag KG, Winthrop K, Curtis JR.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1719-21. doi: 10.1002/acr.22219. No abstract available.

PMID:
24591413
[PubMed - indexed for MEDLINE]
13.

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.

Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, DuVall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):990-7. doi: 10.1002/acr.22281.

PMID:
24470378
[PubMed - indexed for MEDLINE]
14.

Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids.

Warriner AH, Saag KG.

Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):510-6. doi: 10.1097/01.med.0000436249.84273.7b.

PMID:
24468753
[PubMed - in process]
15.

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

FitzGerald G, Compston JE, Chapurlat RD, Pfeilschifter J, Cooper C, Hosmer DW Jr, Adachi JD, Anderson FA Jr, Díez-Pérez A, Greenspan SL, Netelenbos JC, Nieves JW, Rossini M, Watts NB, Hooven FH, LaCroix AZ, March L, Roux C, Saag KG, Siris ES, Silverman S, Gehlbach SH.

J Clin Endocrinol Metab. 2014 Mar;99(3):817-26. doi: 10.1210/jc.2013-3468. Epub 2014 Jan 1.

PMID:
24423345
[PubMed - indexed for MEDLINE]
16.

Trends in the utilization and outcomes of Medicare patients hospitalized for hip fracture, 2000-2008.

Becker DJ, Arora T, Kilgore ML, Curtis JR, Delzell E, Saag KG, Yun H, Morrisey MA.

J Aging Health. 2014 Apr;26(3):360-79. doi: 10.1177/0898264313516994. Epub 2014 Jan 8.

PMID:
24401322
[PubMed - indexed for MEDLINE]
17.

RE: Drug risk assessment and data reuse.

Toh S, Avorn J, D'Agostino RB Sr, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):109-10. doi: 10.1002/pds.3525. No abstract available.

PMID:
24395550
[PubMed - indexed for MEDLINE]
18.

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

Costa AG, Wyman A, Siris ES, Watts NB, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Compston JE, Chapurlat RD, Boonen S, Anderson FA Jr, Adachi JD, Adami S.

PLoS One. 2013 Dec 11;8(12):e83306. doi: 10.1371/journal.pone.0083306. eCollection 2013.

PMID:
24349484
[PubMed - in process]
Free PMC Article
19.

Use of health plan combined with registry data to predict clinical trial recruitment.

Curtis JR, Wright NC, Xie F, Chen L, Zhang J, Saag KG, Bharat A, Kremer J, Cofield S, Winthrop K, Delzell E.

Clin Trials. 2014 Feb;11(1):96-101. doi: 10.1177/1740774513512185. Epub 2013 Dec 17.

PMID:
24346611
[PubMed - in process]
20.

OMERACT endorsement of measures of outcome for studies of acute gout.

Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL.

J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15.

PMID:
24334651
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk